Details for New Drug Application (NDA): 007513
✉ Email this page to a colleague
NDA 007513 describes LEVOPHED, which is a drug marketed by Hospira and is included in one NDA. It is available from two suppliers. Additional details are available on the LEVOPHED profile page.
The generic ingredient in LEVOPHED is norepinephrine bitartrate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
The generic ingredient in LEVOPHED is norepinephrine bitartrate. There are five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the norepinephrine bitartrate profile page.
Summary for 007513
| Tradename: | LEVOPHED |
| Applicant: | Hospira |
| Ingredient: | norepinephrine bitartrate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 007513
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LEVOPHED | norepinephrine bitartrate | INJECTABLE;INJECTION | 007513 | NDA | Hospira, Inc. | 0409-0161 | 0409-0161-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-0161-10) / 4 mL in 1 VIAL, SINGLE-DOSE (0409-0161-01) |
| LEVOPHED | norepinephrine bitartrate | INJECTABLE;INJECTION | 007513 | NDA | Hospira, Inc. | 0409-3375 | 0409-3375-04 | 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3375-04) / 4 mL in 1 VIAL, SINGLE-DOSE (0409-3375-14) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 1MG BASE/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AP | RLD: | Yes | ||||
Complete Access Available with Subscription
